Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.
about
Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampusNutritional interventions for the adjunctive treatment of schizophrenia: a brief reviewA review of the biologic and pharmacologic role of docosapentaenoic acid n-3Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effectsDeficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiencyBRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION.Is dietary pattern of schizophrenia patients different from healthy subjects?Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control studyLinoleic Acid: A Nutritional QuandaryPhospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid speciesEssential fatty acids and psychiatric disorders.Biomarkers and clinical staging in psychiatryPredictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis.Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan.Evidence for a role of the arachidonic acid cascade in affective disorders: a review.Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients.Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 StudyWhite matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.Fat food for a bad mood. Could we treat and prevent depression in Type 2 diabetes by means of omega-3 polyunsaturated fatty acids? A review of the evidence.Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania.A structure-function mechanism for schizophrenia.Tardive dyskinesia and essential fatty acids.Current clinical applications of omega-6 and omega-3 fatty acids.Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy ControlsAlterations in levels and ratios of n-3 and n-6 polyunsaturated fatty acids in the temporal cortex and liver of vervet monkeys from birth to early adulthoodPolyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis.Dietary fat in relation to erythrocyte fatty acid composition in menIs there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials.Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency.The use of omega-3 fatty acids in mental illness.Fatty acid and vitamin interventions in adults with schizophrenia: a systematic review of the current evidence.Update on ω-3 polyunsaturated fatty acids in early-stage psychotic disorders.TRPV1 is a novel target for omega-3 polyunsaturated fatty acids.Alterations in erythrocyte fatty acid composition in preclinical Alzheimer's disease.Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases.Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery Disease.Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals
P2860
Q24677079-7A5966CA-8C75-40AD-A691-9FD36A04A8FFQ28248117-D115FD8F-7CAF-4182-AC04-A523FAFFB47DQ28248251-F22D88E2-0C28-41FE-81A7-B1C45C8C7120Q28578394-11638288-21CA-432C-972A-A3236CC9C420Q30478334-1ADB133D-A507-4714-B6BF-784AC80E30E2Q30493846-078DCBD8-7838-4874-96DA-972A3A7A5A7CQ33283456-21FB7822-C962-4372-B8B3-711000F5A783Q33586155-1CA814E3-F3EB-42A7-AA0C-A7EC0BBCBB78Q33856000-E855C558-155D-40DC-ACB3-B714F2125020Q33937616-C1AB04D8-BB25-41CE-B1F3-1E31B5A071EFQ34202271-22400E6A-CE05-4367-A92D-D01B02E59D21Q34447051-60EB5E1F-6265-43C7-859F-E2624AE2CBE5Q35034786-0965CC99-8BEC-442E-9351-6AFE21A458F2Q35110705-640BD1A3-D8B0-4783-AD7C-56F7E1C0561CQ35670890-C7B15BEF-E6A7-452A-A477-C4B62B4DFE51Q35684403-AD3E1C4C-B034-4824-AA47-37178C1F9F7FQ35793350-C1A49089-3EA7-4478-9F9E-588A00645B6FQ35952743-20E27E9A-54F9-4263-AB47-09B1DCBB75C0Q36102040-79893B6E-8D46-4536-8D32-999E36C86324Q36293473-40F49671-279B-4C35-A78D-6EA56A42DB49Q36453631-F2526A3E-24F8-44BE-852A-511BE7DE6081Q36493182-002FCC88-C640-4F10-BAFD-EEF4C44B0308Q36508056-9C5779E9-5D05-46F6-9C99-ABA111933C82Q36548128-F07659A9-D562-475A-A741-D2E69D15B255Q36580009-32887A01-F457-4327-A100-94C43A37590BQ36635822-9B09179D-49F3-4019-9018-A9FDF8622132Q36940037-474B109E-C823-486B-B501-B8C017924DB1Q37298449-D3B42DEF-9B21-409A-9DA8-641E72CE88A0Q37349962-84693EB7-59DA-4163-823E-400C1E84879FQ37381202-4397C35D-6EC7-4057-9920-3297CDD6CF19Q37937303-7FCBC946-7EF3-4252-9372-5EE434B4CEBBQ38583706-8E4FF988-5B59-4B90-B630-01B83C61EC57Q39794302-4E1A0FA0-7565-4653-BD32-A4E0598FD775Q40220632-A0A959F2-075B-4103-8E39-EC1B89DDE11DQ40261286-314282F0-CAC3-4F18-96CB-7951275B7414Q47148039-E2DADB90-44C6-4385-B666-BA215F319358Q55418695-63917413-3BAB-4096-B706-8072FA67E0D6Q59210038-AA3A25FB-4DBE-402B-9377-1B88E64C1754
P2860
Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Significantly reduced docosahe ...... refully matched control group.
@en
Significantly reduced docosahe ...... refully matched control group.
@nl
type
label
Significantly reduced docosahe ...... refully matched control group.
@en
Significantly reduced docosahe ...... refully matched control group.
@nl
prefLabel
Significantly reduced docosahe ...... refully matched control group.
@en
Significantly reduced docosahe ...... refully matched control group.
@nl
P2093
P1476
Significantly reduced docosahe ...... refully matched control group.
@en
P2093
D H Linszen
P M Dingemans
R J Wanders
R Lieverse
P304
P356
10.1016/S0006-3223(00)00986-0
P407
P577
2001-03-01T00:00:00Z